Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
BMJ Open Ophthalmol ; 5(1): e000495, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-2273812
2.
J Allergy Clin Immunol ; 146(3): 544, 2020 09.
Artículo en Inglés | MEDLINE | ID: covidwho-1382464
3.
Cornea ; 41(3): 339-346, 2022 03 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1865000

RESUMEN

PURPOSE: The purpose of this study was to assess the medical history of adenoviral keratoconjunctivitis (AK) and subepithelial infiltrates (SEIs) among French ophthalmologists and orthoptists and the frequency of unreported occupational diseases. We also described short-term and long-term consequences of AK and evaluated associated factors. METHODS: The REDCap questionnaire was diffused online several times over 7 consecutive months, from October 2019 to May 2020, through mailing lists (French Society of Ophthalmology, residents, and hospital departments), social networks, and by word of mouth. RESULTS: Seven hundred ten participants were included with a response rate of 6.2% for ophthalmologists, 3.8% for orthoptists, and 28.3% for ophthalmology residents. The medical history of AK was found in 24.1% (95% confidence interval 21%-27.2%) of respondents and SEI in 43.9% (36.5%-51.3%) of the AK population. In total, 87.1% (82.1%-92.1%) of AK occupational diseases were not declared. In total, 57.7% of respondents took 9.4 ± 6.2 days of sick leave, mostly unofficial, and 95.7% stopped surgeries for 13.0 ± 6.6 days. Among the AK population, 39.8% had current sequelae, with 17.5% having persistent SEIs, 19.9% using current therapy, and 16.4% experiencing continuing discomfort. SEIs were associated with wearing contact lenses (odds ratio 3.31, 95% confidence interval 1.19-9.21) and smoking (4.07, 1.30-12.8). Corticosteroid therapy was associated with a greater number of sequelae (3.84, 1.51-9.75). CONCLUSIONS: AK and SEI affect a large proportion of ophthalmologists and orthoptists, possibly for years, with high morbidity leading to occupational discomfort. Few practitioners asked for either to be recognized as an occupational disease. Associated factors would require a dedicated study.


Asunto(s)
Infecciones por Adenovirus Humanos/complicaciones , Infecciones Virales del Ojo/complicaciones , Queratoconjuntivitis/complicaciones , Oftalmólogos/estadística & datos numéricos , Ortóptica/estadística & datos numéricos , Medición de Riesgo/métodos , Baja Visión/etiología , Infecciones por Adenovirus Humanos/epidemiología , Adulto , Anciano , Estudios Transversales , Infecciones Virales del Ojo/epidemiología , Femenino , Estudios de Seguimiento , Francia/epidemiología , Humanos , Queratoconjuntivitis/epidemiología , Masculino , Persona de Mediana Edad , Morbilidad/tendencias , Estudios Retrospectivos , Factores de Riesgo , Encuestas y Cuestionarios , Factores de Tiempo , Baja Visión/epidemiología , Agudeza Visual , Adulto Joven
5.
J Allergy Clin Immunol ; 146(2): 332-334, 2020 08.
Artículo en Inglés | MEDLINE | ID: covidwho-739889
7.
Am J Ophthalmol Case Rep ; 19: 100735, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: covidwho-186521

RESUMEN

PURPOSE: To describe the multiplicity of ocular manifestations of COVID-19 patients, we report a case of pseudomembranous and hemorrhagic conjunctivitis related with SARS-CoV-2 pneumonia in a patient of intensive care unit (ICU). OBSERVATIONS: A 63-year-old male was admitted in intensive care unit (ICU), seven days after the beginning of an influenza-like symptoms, to manage an acute respiratory syndrome related with SARS-CoV-2. Chest scan showed interstitial pneumonia with "crazy paving" patterns. At day 19, ocular examination at the patient's bed described petechias and tarsal hemorrhages, mucous filaments and tarsal pseudomembranous. Conjunctival scrapings and swabs did not identify any bacteria or virus. To our knowledge, we described the first case of pseudomembranous conjunctivitis in a COVID-19 patient. CONCLUSION AND IMPORTANCE: Considering that SARS-CoV-2 is present in tears and conjunctival secretions, external ocular infections could be factors of infectious spreading. Physicians should be aware of late (>2 weeks) ocular complications in COVID-19 patients to prevent sequelae.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA